Project Grant K23HL186357
- Federal Project Grant Award Summary The University of Colorado-Denver received a $468,000 Project Grant award dated July 24, 2025, from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). This award, with a completion date of June 30, 2027, funds a research initiative examining weight loss maintenance mechanisms following dietary interventions. The project extends an ongoing one-year dietary weight loss intervention by adding...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), awarded $169,992 to the University of Colorado-Denver on September 18, 2025, to support a mixed-methods research study titled "Start Strong." This K01 mentored career development award funds research investigating optimal antihypertensive medication initiation strategies and will generate evidence for a future pragmatic trial testing a...
- The National Institutes of Health's National Heart, Lung and Blood Institute awarded $2,350,623 under the Cardiovascular Diseases Research program (CFDA 93.837) to the Regents of the University of Minnesota on May 1, 2021 for a project concluding on April 30, 2022. The project aims to reduce childhood obesity through an individual randomized controlled trial testing combinations of ecological momentary intervention, home visiting, and video feedback delivered to 510 low-income, racially...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded University of Colorado-Denver a $150,104 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) effective January 26, 2026, with a completion date of December 31, 2028. The grant funds basic research investigating lysine myristoylation as a novel regulatory mechanism for protein kinase A (PKA) in cardiac tissue. The research addresses the clinical need for alternative PKA...
- Federal Grant Award Summary Colorado State University received a $453,556 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, through July 31, 2028. The award funds development and evaluation of a digitally enhanced cognitive-behavioral therapy (CBT) intervention designed to treat depression and improve cardiometabolic health outcomes in adolescents (ages 12-17) with elevated...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Leland Stanford Junior University a $166,968 Project Grant (CFDA 93.837: Cardiovascular Diseases Research) on September 15, 2025, with completion targeted for June 30, 2030. This research initiative delivers a community-engaged intervention study designed to reduce ultra-processed food (UPF) consumption in preschool children, specifically toddlers aged 2–3 years, to improve cardiovascular health...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Virginia a $732,261 Project Grant on September 15, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to support research on the genetic factors underlying central obesity. The project, "Leveraging Large-Scale Multi-Ethnic, Multi-Omic Data for Functional Analysis of Central Obesity Loci," will identify putative causal genes associated with central...
- Federal Grant Award Summary Temple University received a $237,750 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025 through July 31, 2027. Under this R03 award, Principal Investigator Gabriella McLoughlin, PhD, MS, will conduct research investigating the impact of an equity-focused implementation strategy on participation and uptake of Universal School Meals (USM) among...
- Federal Project Grant Award Summary The University of California, San Francisco received a $100,998 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded August 19, 2025, with completion targeted for August 31, 2027. This research initiative will deliver a comprehensive population-based investigation evaluating the effects of universal pre-kindergarten (Pre-K) access policies on parents' cardiovascular...
- Federal Project Grant Award Summary Cincinnati Children's Hospital Medical Center received a $191,636 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective April 1, 2026, through March 31, 2031. This award supports a longitudinal research study examining the relationships between food insecurity, loss of control eating, and cardiometabolic health risk in Hispanic/Latino adolescents. The study will...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a Project Grant of $169,225 (Award Date: July 1, 2026; Ultimate Completion Date: April 30, 2031) under the Cardiovascular Diseases Research program (CFDA 93.837) to The Regents of the University of Colorado, doing business as University of Colorado-Denver, to conduct research on obesity interventions in preschool-aged children. Dr. Rochelle Cason-Wilkerson, the principal investigator, will lead the Targeted Intervention and Process Strategies (TIPS) initiative, which adapts an existing hospital-based weight management clinical program to address high attrition rates and improve health outcomes for families with preschool-aged children (ages 2-5 years). The research deliverables include the adaptation of existing weight management care processes using co-creation methodologies to support the unique needs of families, identification and modification of implementation strategies to reduce attrition, and integration of health navigator-provider partnerships with flexible appointment modalities. The project will screen and refer families for supportive services designed to address common barriers to treatment engagement and success. Through mixed-methods research, the study will generate evidence on effective implementation strategies to decrease program attrition and improve lifestyle modifications and health outcomes in this underserved pediatric population, contributing to the research evidence base for obesity prevention and management in early childhood.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $169.2k | 6/11/26 |